Enacademic 🎓Analogindex
49 subscribers
77.3K photos
5 videos
249K links
Download Telegram
*Форменная одежда ВКС*

1 августа 2015 года был создан новый род войск, который получил название воздушно-космические силы, для этого были объединены военно-воздушные силы и войска...via forma full 5 https://ift.tt/wqe2sLK Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3578220.html)
Форменная одежда ВКС

1 августа 2015 года был создан новый род войск, который получил название воздушно-космические силы, для этого были объединены военно-воздушные силы и войска...via forma full 5 https://ift.tt/wqe2sLK Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...
*Аксельбант*

via forma full 5 https://ift.tt/borGT3P Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3575917.html)
*NHL teams follow NFL, NBA, and MLB with impressive billion-dollar gains*

Ryan Reynolds and Snoop Dogg were in a bidding war earlier this year. The two celebrities wanted to become the owners of the NHL's Ottawa Senators, and were bidding around $1 billion for the team. Neither was able to secure the bid — instead the sale went to Canadian businessman Michael Andlauer for $950 million, a number that was 45% more than the $655 million valuation Sportico gave the team in 2022. But sports teams valuations have been growing at a steep rate. The NFL's Washington Commanders were sold for $6.05 billion in July, and were valued at $4.78 billion by Sportico less than a year prior to the sale. While NHL teams are no where near the peak valuation of some of the biggest teams in the NFL or NBA, the league's franchises have followed the other major sports by showing a massive leap in valuation over the last year. Related: Tom Brady, Ryan Reynolds, and Shaq keep investing in sports teams. Here's why According to the 2023 NHL team valuations Sportico released on Wednesday, the averaged NHL team is now worth $1.31 billion, up 29% from 2022. The Toronto Maple Leafs lead the pack with a valuation of $2.65 billion, which is up 25% versus last year. The biggest year-on-year percent gain went to the Carolina Hurricanes, now valued at $980 million which is up 59% versus 2022. Ten of the league's 32 teams are still worth less than a billion dollars, but there is a steep gap between the 31st team, the Columbus Blue Jackets ($880 million) and the Arizona Coyotes ($675 million). Though the Coyotes still saw growth of 45% in 2023. The other three major men's sports leagues have seen double-digit growth on average year-on-year valuation for its teams, at least based on Forbes' valuations. But the difference between the the NHL and the other three major leagues — and what makes it similar to what's becoming the fifth men's major sports league, Major League Soccer — is that there is more parity in valuation between the teams.Related: Inside Haley Cavinder's decision to return to basketball including next steps with WWE Sportico's Lev Akabas showed that there are huge gaps in value in the NHL with the Dallas Cowboys ($9.2 billion) valued at least $2 billion more than the next closest team. In the NBA, the Golden State Warriors ($7.56 billion) are valued at just under a billion more than the New York Knicks and Los Angeles Lakers, who are both valued billions more than the rest of the league. Though the NBA valuations from Sportico are still as of 2022. In the MLB, the New York Yankees ($7.13 billion) have a wide gap from the next four teams — the Boston Red Sox, Los Angeles Dodgers, Chicago Cubs, and San Francisco Giants — who themselves have separated from the pack. But in the NHL and MLS, there isn't yet that separation between the top teams. This is attributed to a few things — such revenue generation which could be based on how many of NHL's top teams are in Canada. .@Sportico's NHL valuations dropped todayHere are all valuations for the five major U.S. sports leagues in one graphic pic.twitter.com/H4kv6jYXeZ— Lev Akabas (@LevAkabas) November 8, 2023 Get exclusive access to portfolio managers and their proven investing strategies with Real Money Pro. Get started now.
[Read more...](https://www.thestreet.com/sports/nhl-teams-follow-nba-nfl-mlb-with-billion-dollar-gains)
NHL teams follow NFL, NBA, and MLB with impressive billion-dollar gains

Ryan Reynolds and Snoop Dogg were in a bidding war earlier this year. The two celebrities wanted to become the owners of the NHL's Ottawa Senators, and were bidding around $1 billion for the team. Neither was able to secure the bid — instead the sale went to Canadian businessman Michael Andlauer for $950 million, a number that was 45% more than the $655 million valuation Sportico gave the team in 2022. But sports teams valuations have been growing at a steep rate. The NFL's Washington Commanders were sold for $6.05 billion in July, and were valued at $4.78 billion by Sportico less than a year prior to the sale. While NHL teams are no where near the peak valuation of some of the biggest teams in the NFL or NBA, the league's franchises have followed the other major sports by showing a massive leap in valuation over the last year. Related: Tom Brady, Ryan Reynolds, and Shaq keep investing in sports teams. Here's why According to the 2023 NHL team valuations Sportico released on Wednesday, the averaged NHL team is now worth $1.31 billion, up 29% from 2022. The Toronto Maple Leafs lead the pack with a valuation of $2.65 billion, which is up 25% versus last year. The biggest year-on-year percent gain went to the Carolina Hurricanes, now valued at $980 million which is up 59% versus 2022. Ten of the league's 32 teams are still worth less than a billion dollars, but there is a steep gap between the 31st team, the Columbus Blue Jackets ($880 million) and the Arizona Coyotes ($675 million). Though the Coyotes still saw growth of 45% in 2023. The other three major men's sports leagues have seen double-digit growth on average year-on-year valuation for its teams, at least based on Forbes' valuations. But the difference between the the NHL and the other three major leagues — and what makes it similar to what's becoming the fifth men's major sports league, Major League Soccer — is that there is more parity in valuation between the teams.Related: Inside Haley Cavinder's decision to return to basketball including next steps with WWE Sportico's Lev Akabas showed that there are huge gaps in value in the NHL with the Dallas Cowboys ($9.2 billion) valued at least $2 billion more than the next closest team. In the NBA, the Golden State Warriors ($7.56 billion) are valued at just under a billion more than the New York Knicks and Los Angeles Lakers, who are both valued billions more than the rest of the league. Though the NBA valuations from Sportico are still as of 2022. In the MLB, the New York Yankees ($7.13 billion) have a wide gap from the next four teams — the Boston Red Sox, Los Angeles Dodgers, Chicago Cubs, and San Francisco Giants — who themselves have separated from the pack. But in the NHL and MLS, there isn't yet that separation between the top teams. This is attributed to a few things — such revenue generation which could be based on how many of NHL's top teams are in Canada. .@Sportico's NHL valuations dropped todayHere are all valuations for the five major U.S. sports leagues in one graphic pic.twitter.com/H4kv6jYXeZ— Lev Akabas (@LevAkabas) November 8, 2023 Get exclusive access to portfolio managers and their proven investing strategies with Real Money Pro. Get started now.
Read more...
*NASA’s Free Streaming Service Is Launching More than Rockets*

There are already three shows (including an animated series) coming to the platform. READ MORE...
[Read more...](https://www.apartmenttherapy.com/nasa-plus-streaming-service-37338592?utm_source=RSS&utm_medium=feed&utm_campaign=Category%2FChannel%3A+main)
*LEGO показала рекордно большой набор по вселенной Marvel — «Башню Мстителей»*

Он включает фигурки всех знаковых персонажей «Саги Бесконечности».
[Read more...](https://lifehacker.ru/nabor-lego-bashnya-mstitelej/)
*Почему люди охотно пересылают страшилки в мессенджерах и как отличить правду от вымысла*

Это происходит не из-за глупости.
[Read more...](https://lifehacker.ru/strashilki-v-messendzherax/)
*Cathie Wood sinks nearly $2 million into falling tech stock*

Cathie Wood, CEO and investment lead of Ark Invest, loves her disruptive tech stocks. While a prominent aspect of Ark’s funds is made up of more traditional tech names, such as Tesla TSLA, the firm has snapped up plenty of shares in biotechnology companies over the years. Ark bought a total of 268,772 shares of Pacific Biosciences PACB on Nov. 7. The bulk of this purchase was made by Ark’s Innovation ETF. The firm also purchased a total of 468,261 shares of Ginkgo Bioworks DNA and 13,596 shares of 10x Genomics TXG – Ark Innovation carried the bulk of these purchases as well. After reaching a 52-week-high of $14.05 in July, PacBio’s stock has been on the decline. The company’s shares are down nearly 20% for the year, closing Nov. 7 at $6.88. Reporting third-quarter results in October, the company noted a net loss of 26 cents per share, below the loss of 34 cents per share it reported in the year-ago period. Also, the company reported revenue of $55.7 million for the quarter, a 72% year-over-year increase. Related: Cathie Wood snaps up $5 million in one disruptive tech stock "PacBio had another successful quarter as we continued to drive Revio adoption and exceeded $50 million in quarterly revenue for the first time in company history," Christian Henry, president and CEO of PacBio said in a statement at the time. Analysts have rated the company a moderate buy. Also, according to its Piotroski F-Score, which rates a company’s financial health from 0-9, PacBio has a score of three. Ark Innovation’s holding in PacBio, worth just under $130 million, makes up 1.78% of the fund. Ginkgo, which reports earnings after the bell Nov. 8, closed the previous session at $1.54 per share. The company’s stock is down 11% for the year. For 10x Genomics, its stock is up a little more than 3% for the year, and it closed the previous session at $39.02. Since the summer of 2022, Wood has been purchasing biotech stocks en masse. In a 2021 interview with CNBC, Ark Invest analyst Simon Barnett said that Ark sees genomics as “one of the most transformative investment opportunities of the century.”
[Read more...](https://www.thestreet.com/investing/cathie-wood-sinks-nearly-2-million-into-falling-tech-stock)
Cathie Wood sinks nearly $2 million into falling tech stock

Cathie Wood, CEO and investment lead of Ark Invest, loves her disruptive tech stocks. While a prominent aspect of Ark’s funds is made up of more traditional tech names, such as Tesla TSLA, the firm has snapped up plenty of shares in biotechnology companies over the years. Ark bought a total of 268,772 shares of Pacific Biosciences PACB on Nov. 7. The bulk of this purchase was made by Ark’s Innovation ETF. The firm also purchased a total of 468,261 shares of Ginkgo Bioworks DNA and 13,596 shares of 10x Genomics TXG – Ark Innovation carried the bulk of these purchases as well. After reaching a 52-week-high of $14.05 in July, PacBio’s stock has been on the decline. The company’s shares are down nearly 20% for the year, closing Nov. 7 at $6.88. Reporting third-quarter results in October, the company noted a net loss of 26 cents per share, below the loss of 34 cents per share it reported in the year-ago period. Also, the company reported revenue of $55.7 million for the quarter, a 72% year-over-year increase. Related: Cathie Wood snaps up $5 million in one disruptive tech stock "PacBio had another successful quarter as we continued to drive Revio adoption and exceeded $50 million in quarterly revenue for the first time in company history," Christian Henry, president and CEO of PacBio said in a statement at the time. Analysts have rated the company a moderate buy. Also, according to its Piotroski F-Score, which rates a company’s financial health from 0-9, PacBio has a score of three. Ark Innovation’s holding in PacBio, worth just under $130 million, makes up 1.78% of the fund. Ginkgo, which reports earnings after the bell Nov. 8, closed the previous session at $1.54 per share. The company’s stock is down 11% for the year. For 10x Genomics, its stock is up a little more than 3% for the year, and it closed the previous session at $39.02. Since the summer of 2022, Wood has been purchasing biotech stocks en masse. In a 2021 interview with CNBC, Ark Invest analyst Simon Barnett said that Ark sees genomics as “one of the most transformative investment opportunities of the century.”
Read more...
*Аксельбант*

via forma full 5 https://ift.tt/borGT3P Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3575917.html)
*OREO Wants to Reward You for Putting Up Holiday Decorations Early*

Decorating early could score you a fresh pile of cash … and a pile of cookies. READ MORE...
[Read more...](https://www.apartmenttherapy.com/oreo-hoa-contest-2023-37338599?utm_source=RSS&utm_medium=feed&utm_campaign=Category%2FChannel%3A+main)
*The Unexpected and Trendy Water Bottle Accessory That’ll Make Your Life So Much Easier*

Stay hydrated on the go — the convenient way. READ MORE...
[Read more...](https://www.apartmenttherapy.com/wanderfull-hydrobag-review-37338262?utm_source=RSS&utm_medium=feed&utm_campaign=Category%2FChannel%3A+main)